158 related articles for article (PubMed ID: 24936238)
1. Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor.
Shi Q; Yin S; Kaluz S; Ni N; Devi NS; Mun J; Wang D; Damera K; Chen W; Burroughs S; Mooring SR; Goodman MM; Van Meir EG; Wang B; Snyder JP
ACS Med Chem Lett; 2012 Aug; 3(8):620-5. PubMed ID: 24936238
[TBL] [Abstract][Full Text] [Related]
2. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
3. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM
Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
6. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
7. CTK7A, a curcumin derivative, can be a potential candidate for targeting HIF-1α/p300 complex: Evidences from in vitro and computational studies.
Rath S; Jena AB; Bhattacharyya A; Dandapat J
Biophys Chem; 2022 Aug; 287():106828. PubMed ID: 35635894
[TBL] [Abstract][Full Text] [Related]
8. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
[TBL] [Abstract][Full Text] [Related]
9. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
[TBL] [Abstract][Full Text] [Related]
10. Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.
Chan ST; Patel PR; Ransom TR; Henrich CJ; McKee TC; Goey AK; Cook KM; Figg WD; McMahon JB; Schnermann MJ; Gustafson KR
J Am Chem Soc; 2015 Apr; 137(16):5569-75. PubMed ID: 25892103
[TBL] [Abstract][Full Text] [Related]
11. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
12. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
Schmid T; Zhou J; Köhl R; Brüne B
Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
[TBL] [Abstract][Full Text] [Related]
13. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
Cho H; Ahn DR; Park H; Yang EG
FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
[TBL] [Abstract][Full Text] [Related]
14. Mammalian gene expression program resiliency: the roles of multiple coactivator mechanisms in hypoxia-responsive transcription.
Kasper LH; Brindle PK
Cell Cycle; 2006 Jan; 5(2):142-6. PubMed ID: 16357535
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
[TBL] [Abstract][Full Text] [Related]
16. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
17. Roles of coactivators in hypoxic induction of the erythropoietin gene.
Wang F; Zhang R; Wu X; Hankinson O
PLoS One; 2010 Apr; 5(4):e10002. PubMed ID: 20368990
[TBL] [Abstract][Full Text] [Related]
18. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.
Kasper LH; Boussouar F; Boyd K; Xu W; Biesen M; Rehg J; Baudino TA; Cleveland JL; Brindle PK
EMBO J; 2005 Nov; 24(22):3846-58. PubMed ID: 16237459
[TBL] [Abstract][Full Text] [Related]
19. The acetylase/deacetylase couple CREB-binding protein/Sirtuin 1 controls hypoxia-inducible factor 2 signaling.
Chen R; Xu M; Hogg RT; Li J; Little B; Gerard RD; Garcia JA
J Biol Chem; 2012 Aug; 287(36):30800-11. PubMed ID: 22807441
[TBL] [Abstract][Full Text] [Related]
20. Three conformational states of the p300 CH1 domain define its functional properties.
Dial R; Sun ZY; Freedman SJ
Biochemistry; 2003 Aug; 42(33):9937-45. PubMed ID: 12924942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
